Faculty Information - HOSHINO Junichi

Published papers

Academic conference presentation

Qualifications & licenses

Research areas

Awards & honors

Academic society memberships

Education

Academic & professional experience

（Last updated : 2024-07-25 16:43:05）

HOSHINO Junichi
Department School of Medicine(Tokyo Women's Medical University Hospital), School of Medicine Department of Internal Medicine, Division of Nephrology

Position Professor and Division head

■ Published papers

1.	Original article	Gross Hematuria after the COVID-19 mRNA Vaccination: Nationwide Multicenter Prospective Cohort Study in Japan 2024/07/08
2.	Original article	Aberrant proximal tubule DNA methylation underlies phenotypic changes related to kidney dysfunction in patients with diabetes 2024/07/04
3.	Review article	Immediate drop of urine osmolality upon tolvaptan initiation predicts impact on renal prognosis in patients with ADPKD 2024/05/31
4.	Original article	Protocol for the nationwide registry of patients with polycystic kidney disease: japanese national registry of PKD (JRP) 2024/05/11
5.	Original article	Genetic Analysis of Severe Polycystic Liver Disease in Japan 2024/05/01
6.	Original article	Exercise instruction during haemodialysis treatment after changes to the insurance regime: a nationwide questionnaire survey in Japan 2024/04/22
7.	Original article	Renal outcome of living kidney donors aged more than 70 years 2024/04/14
8.	Original article	A toolkit for ISN's registry initiative, SharE-RR 2024/04
9.	Original article	Diagnostic value of 18F-fluorodeoxyglucose positron emission tomography and computed tomography for differentiating polymyalgia rheumatica and rheumatoid arthritis: Using classification and regression tree analysis 2024/03/28
10.	Original article	Diagnostic value of 18F-fluorodeoxyglucose positron emission tomography and computed tomography for differentiating polymyalgia rheumatica and rheumatoid arthritis: Using classification and regression tree analysis 2024/03/28
11.	Original article	Health-related Quality of Life in 10 years Long-term Survivors of Chronic Kidney Disease: A From-J Study. 2024/03
12.	Original article	Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022 2024/02/28
13.	Case report	PLA2R-positive membranous nephropathy in IgG4-related disease 2024/02/23
14.	Original article	Factors associated with early-onset intracranial aneurysms in patients with autosomal dominant polycystic kidney disease 2024/02/05
15.	Original article	Autopsy of a 45-year-old Man with Liver Failure Due to Polycystic Liver Disease 2024/02/01
16.	Original article	Correction to: Clinical questions and good practice statements of clinical practice guidelines for management of kidney injury during anticancer drug therapy 2022. 2024/02
17.	Original article	Correction to: Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease 2024/01
18.	Original article	Minimum-incision transsubclavian transcatheter aortic valve replacement with balloon-expandable valve for dialysis patients. 2024/01
19.	Original article	Polar vasculosis is associated with better kidney outcome in type 2 diabetes with biopsy-proven diabetic kidney disease: A multicenter cohort study. 2023/11/14
20.	Original article	Trajectory of GFR Decline and Fluctuation in Albuminuria Leading to End-Stage Kidney Disease in Patients With Biopsy-Confirmed Diabetic Kidney Disease. 2023/11/10
21.	Case report	Secondary spontaneous pneumothorax in a patient with resistant Mycobacterium abscessus infection and systemic sclerosis-associated interstitial lung disease: A case report 2023/11/05
22.	Original article	Immediate drop of urine osmolality upon tolvaptan initiation predicts impact on renal prognosis in patients with ADPKD. 2023/11/03
23.	Original article	Serum oxalate concentration is associated with coronary artery calcification and cardiovascular events in Japanese dialysis patients. 2023/10/29
24.	Original article	Chapter 1: Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022 2023/10/28
25.	Original article	Chapter 2:indications and dosing of anticancer drug therapy in patients with impaired kidney function, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022. 2023/10/28
26.	Original article	Chapter 3: Management of kidney injury caused by cancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022. 2023/10/28
27.	Original article	Chapter 4: CKD treatment in cancer survivors, from Clinical Practice Guidelines for the Management of Kidney Injury During Anticancer Drug Therapy 2022. 2023/10/28
28.	Original article	がん薬物療法時の腎障害診療ガイドライン2022(第1章)　がん薬物療法対象患者の腎機能評価(Chapter 1: Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022) 2023/10/28
29.	Original article	がん薬物療法時の腎障害診療ガイドライン2022(第2章)　腎機能障害患者に対するがん薬物療法の適応と投与方法(Chapter 2: indications and dosing of anticancer drug therapy in patients with impaired kidney function, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022) 2023/10/28
30.	Original article	がん薬物療法時の腎障害診療ガイドライン2022(第3章)　がん薬物療法による腎障害への対策(Chapter 3: Management of kidney injury caused by cancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer drug therapy 2022) 2023/10/28
31.	Original article	がん薬物療法時の腎障害診療ガイドライン2022(第4章)　がんサバイバーのCKD治療(Chapter 4: CKD treatment in cancer survivors, from Clinical Practice Guidelines for the Management of Kidney Injury During Anticancer Drug Therapy 2022) 2023/10/28
32.	Original article	Public support for patients with intractable diseases in Japan: impact on clinical indicators from nationwide registries in patients with autosomal dominant polycystic kidney disease. 2023/10
33.	Original article	JSDT Renal Data Registryによる年次透析データ報告(2019年版)(Annual dialysis data report 2019, JSDT Renal Data Registry) 2023/09/19
34.	Original article	A Case of Rapidly Progressive Diabetic Nephropathy Induced by Osimertinib. 2023/08/08
35.	Original article	Apolipoprotein E-associated Lipoprotein Glomerulo-tubulopathy. 2023/08/01
36.	Original article	Adolescent-onset TAFRO Syndrome with Malignant Nephrosclerosis-like Lesions. 2023/08
37.	Case report	Microbiome of infected cysts, feces and saliva in patients with autosomal dominant polycystic kidney disease. 2023/08
38.	Case report	常染色体優性多発性嚢胞腎患者における感染嚢胞、糞便および唾液のマイクロバイオーム(Microbiome of infected cysts, feces and saliva in patients with autosomal dominant polycystic kidney disease) 2023/08
39.	Original article	Glomerular hyperfiltration and hypertrophy: an evaluation of maximum values in pathological indicators to discriminate "diseased" from "normal" 2023/07/13
40.	Original article	Prolonged scintigraphy in the diagnosis of pleuroperitoneal communication. 2023/07
41.	Review article	Can Takayasu Arteritis Cause Hydronephrosis? 2023/06/01
42.	Review article	高安動脈炎は水腎症を引き起こすか(Can Takayasu Arteritis Cause Hydronephrosis?) 2023/06/01
43.	Review article	Pregnancy after kidney transplantation 2023/05/25
44.	Original article	Glycated albumin to glycated hemoglobin ratio and mortality in diabetic patients on dialysis: a new association. 2023/05/04
45.	Original article	Pregnancy complications and impact on kidney allograft after kidney transplantation in IgA nephropathy. 2023/05/04
46.	Original article	Acute renal intracystic hemorrhage in patients with autosomal dominant polycystic kidney disease. 2023/05
47.	Case report	Crescentic Glomerulonephritis with Fibrinoid Vasculitis after Administration of Influenza Vaccine. 2023/04/01
48.	Case report	Successful Discontinuation of Glucocorticoid Treatment after Administration of a Calcineurin Inhibitor for Nephrotic Syndrome in a Patient with Lupus Nephritis 2023/04/01
49.	Case report	インフルエンザワクチン接種後のフィブリノイド血管炎を伴った半月体形成性糸球体腎炎(Crescentic Glomerulonephritis with Fibrinoid Vasculitis after Administration of Influenza Vaccine) 2023/04/01
50.	Case report	ループス腎炎患者におけるネフローゼ症候群に対するカルシニューリン阻害薬投与後のグルココルチコイド治療中止の成功(Successful Discontinuation of Glucocorticoid Treatment after Administration of a Calcineurin Inhibitor for Nephrotic Syndrome in a Patient with Lupus Nephritis) 2023/04/01
51.	Original article	A Half-Century Dialysis Survivor: Clinical and Autopsy Findings. 2023/04
52.	Case report	常染色体顕性尿細管間質性腎疾患サブタイプ肝細胞核因子1β患者における腎組織学的所見(Kidney Histology Findings in a Patient with Autosomal Dominant Tubulointerstitial Kidney Disease Subtype Hepatocyte Nuclear Factor 1β) 2023/02/01
53.	Original article	A case of malignant nephrosclerosis occurring with serum renin in the normal range 2023/02
54.	Original article	Changes in Kidney and Liver Volumes in Patients With Autosomal Dominant Polycystic Kidney Disease Before and After Dialysis Initiation. 2023/02
55.	Original article	Development of an enterocutaneous fistula from an intestinal perforation in a patient with autosomal dominant polycystic kidney disease 2023/02
56.	Original article	常染色体優性多発性嚢胞腎患者における腸管穿孔からの腸管皮膚瘻の発生(Development of an enterocutaneous fistula from an intestinal perforation in a patient with autosomal dominant polycystic kidney disease) 2023/02
57.	Case report	正常範囲の血清レニンで発症した悪性腎硬化症の1例(A case of malignant nephrosclerosis occurring with serum renin in the normal range) 2023/02
58.	Case report	A Bone Histomorphometric Analysis of Hypophosphatasia-related Osteoporosis after Teriparatide Treatment. 2023/01/01
59.	Case report	Endothelial Damage-dominant Nephritis Related to IgA Vasculitis after 11 Years' Use of Infliximab for Rheumatoid Arthritis. 2023/01/01
60.	Original article	テリパラチド治療後の低ホスファターゼ血症関連骨粗鬆症の骨組織形態学的解析(A Bone Histomorphometric Analysis of Hypophosphatasia-related Osteoporosis after Teriparatide Treatment) 2023/01/01
61.	Case report	関節リウマチに対するインフリキシマブ投与から11年後のIgA血管炎に関連する内皮障害優位腎炎(Endothelial Damage-dominant Nephritis Related to IgA Vasculitis after 11 Years' Use of Infliximab for Rheumatoid Arthritis) 2023/01/01
62.	Original article	Long-term effectiveness of a primary care practice facilitation program for chronic kidney disease management: an extended follow-up of a cluster-randomized FROM-J study. 2023/01
63.	Original article	Kidney Transplantation From a Diabetic Donor to a Nondiabetic Recipient: A Case Report. 2022/12
64.	Original article	Synergistic deterioration of prognosis associated with decreased grip strength and hyporesponse to erythropoiesis-stimulating agents in patients undergoing hemodialysis 2022/12
65.	Review article	Cystic Kidney Diseases That Require a Differential Diagnosis from Autosomal Dominant Polycystic Kidney Disease (ADPKD). 2022/11
66.	Original article	Machine learning for morbid glomerular hypertrophy. 2022/11
67.	Original article	Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease 2022/10/27
68.	Original article	ANCA-Negative Vasculitis in Eosinophilic Granulomatosis with Polyangiitis Complicated with Membranous Nephropathy: A Case Report and Brief Literature Review 2022/05/06
69.	Original article	Echocardiographic Findings and Genotypes in Autosomal Dominant Polycystic Kidney Disease. 2022/05
70.	Original article	Long-term Effectiveness of a Primary Care Practice Facilitation Program for Chronic Kidney Disease Management: An Extended Follow-up of a Cluster-Randomized FROM-J Study. 2022/02
71.	Original article	Activity of daily life dependency predicts the risk of mortality in patients with COVID-19 undergoing hemodialysis: a retrospective analysis of a single center with nosocomial outbreak. 2022
72.	Original article	Potential effect of tolvaptan on polycystic liver disease for patients with ADPKD meeting the Japanese criteria of tolvaptan use. 2022
73.	Original article	Vitamin D-resistant osteomalacia after 10 years of haemodialysis in a patient with rheumatoid arthritis 2021/12/24
74.	Original article	Syphilis-associated membranous nephropathy successfully treated with amoxicillin. 2021/11
75.	Original article	Comparison of annual eGFR decline among primary kidney diseases in patients with CKD G3b-5: results from a REACH-J CKD cohort study. 2021/08
76.	Original article	A case of thrombotic microangiopathy associated with polymyositis 2021/06
77.	Original article	Genetic Background and Clinicopathologic Features of Adult-onset Nephronophthisis 2021/05/04
78.	Original article	Renal Rehabilitation: Exercise Intervention and Nutritional Support in Dialysis Patients 2021/04/24
79.	Original article	Renal Squamous Cell Carcinoma-related Polymyositis in a Patient with Autosomal Dominant Polycystic Kidney Disease. 2021/04/15
80.	Original article	Dialysis-related amyloidosis associated with a novel β2-microglobulin variant. 2021/03
81.	Original article	Tocilizumab preserves renal function in rheumatoid arthritis with AA amyloidosis and end-stage kidney disease: Two case reports. 2021/01
82.	Original article	Autosomal Dominant Tubulointerstitial Kidney Disease HNF1B With Maturity-Onset Diabetes of the Young: A Case Report With Kidney Biopsy. 2020/12/26
83.	Original article	Abatacept Improves Intractable Protein-Losing Enteropathy Secondary to AA Amyloidosis in a Patient With Rheumatoid Arthritis 2020/12
84.	Original article	Diaphyseal femoral fracture due to severe vitamin D3 deficiency and low parathyroid hormone levels on long-term hemodialysis: a case report. 2020/11
85.	Original article	Rapidly progressive glomerulonephritis caused by tegafur/gimeracil/oteracil resulted in diabetes nephropathy, in a patient with minor risk of diabetes nephropathy: a case report. 2020/11
86.	Original article	Methylation pattern of urinary DNA as a marker of kidney function decline in diabetes. 2020/09
87.	Original article	Genetics May Predict Effectiveness of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease. 2020/08
88.	Original article	Nonproteinuric diabetic kidney disease 2020/07
89.	Original article	Clinicopathological features of fast eGFR decliners among patients with diabetic nephropathy. 2020/06
90.	Original article	Prescription of renin-angiotensin-aldosterone system inhibitors (RAASi) and its determinants in patients with advanced CKD under nephrologist care. 2019/09
Display 5 items
Display all(90)

■ Academic conference presentation

1.	Acute kidney injury and erythema multiforme associated with Helicobacter pylori eradication therapy:Not invariably drug allergy. 2023/11/04
2.	Prevalence and characteristics of intracranial aneurysms and cerebral hemorrhage in patients with autosomal dominant polycystic kidney disease in the Japanese nationwide database 2023/11/04
3.	Association between physical activity and renal outcomes in patients with CKD G3b-5: A result from a Japanese cohort study, the REACH-J. 2023/11/03
4.	ADCK4 nephropathy in identical siblings 2023/11/02
5.	High hemoglobin and high ESA responsiveness are good prognostic factors in CKD patients: An attribute-based analysis using a cross-classification approach in the BRIGHTEN study 2023/11/02
6.	Elderly living kidney transplant donors and their renal prognosis. 2023/06/06
Display 5 items
Display all(6)

■ Qualifications & licenses

1.		Japanese Society of Clinical Epidemiology Senior Expert
2.		Japanese Society of Internal Medicine/Japan Dialysis Medical Society　Specialist/Instructor
3.	2023	Director, Japanese Society of Kidney Rehabilitation
4.	2020	Director, Japan Amyloidosis Society
5.	2013	Japanese Society of Rheumatology, Specialist / supervisor / councilor
6.	2011/12	Master of Public Health, Specializing in Epidemiology
7.	2010	Japanese Society of Nephrology, Specialist / supervisor / councilor
8.	2008	American College of Internal Medicine Senior Member (FACP)
Display 5 items
Display all(8)

■ Research areas

Nephrology, Connective tissue disease and allergy

■ Awards & honors

1.	2017/06	Japanese Society for Dialysis Therapy Japanese Society of Dialysis Therapy, Encouragement Award
2.	2017	Totanomon Hospital Totanomon Hospital, Instructor of the Year
3.	2016/06	Japanese Society of Nephrology Japanese Society of Nephrology, Oshima Award
4.	2011/11	American Society of Nephrology Travel Grant
5.	2009/04	Japan College of Rheumatology International Workshop Award
6.	2007/10	Japanese Society of Nephrology Eastern Regional Meeting of Japanese Society of Nephrology, Best Abstract Award
7.	2006/07	European Renal Association, European Dialysis and Transplantation Association ERA-EDTA Congress Award
Display 5 items
Display all(7)

■ Academic society memberships

1.	2019/09～	The Japanese Society of Internal Medicine
2.	2018/09～	The Japan College of Rheumatology
3.	2017/06～	The Japanese Society of Nephrology
4.	2015/06～	The Japanese Society for Renal Rehabilitation
5.	2014/06～	The Japanese Society of Dialysis Therapy

■ Education

1.	2010/09～2011/12	〔Master degree program〕 Epidemiology, School of Public Health, University of California, Los Angeles, Completed, Master of Public Health, Specializing in Epidemiology
2.	2010/04	Graduate School of Comprehensive Human Sciences, Department of Disease Control Medicine, Graduate School, Division of Medicine, University of Tsukuba, Doctor of Medical Sciences
3.	～1997/03	Faculty of Medicine, Yokohama City University, Graduated,

■ Academic & professional experience

1.	2017/04～2022/03	Toranomon Hospital Department of Nephrology, Department of Rheumatology Director
2.	2012～2017/03	Toranomon Hospital Department of Nephrology, Department of Rheumatology director
3.	2002～2011	Toranomon Hospital Department of Nephrology, Department of Rheumatology doctor
4.	1997/04～2001	Toranomon Hospital Internal medicine doctor